Arch Venture Partners
Vizgen Raises $37M in Series B Financing
The Harvard spinout will use the proceeds to commercialize its Merscope technology for spatial transcriptomics and increase manufacturing capacity.
Vizgen Launches With $14M Series A Financing
The firm, cofounded by several Harvard University researchers, is commercializing a single-cell spatial transcriptomics technology called MERFISH.
Gene Editing Firm Homology Medicines Raises $43.5M in Series A Funding
The new company hopes to turn recombinant adeno-associated virus-based gene editing, which has minimal off-target effects, into new therapies.
Codiak BioSciences Launches With $80M Financing to Develop Exosome-Based Products
The new firm will be based in the Boston area and is co-founded by MD Anderson Professor Raghu Kalluri and Broad Institute Director Eric Lander.
Non-Profits, Investors Worry About Proposed Washington State Tax Surcharge Increase
Leroy Hood called the bill short-sighted and said that over the long-term it could potentially reduce the attractiveness of starting up companies in the Seattle area.